D-0732-2022 Class II Terminated
FDA drug recall D-0732-2022 was initiated by Drug Depot, Inc., dba APS Pharmacy on March 23, 2022 and is designated Class II. Reason for recall: Lack of sterility assurance. The recall status is terminated (terminated October 5, 2023). Affected quantity: 620 vials.
Recall Details
- Product Type
- Drugs
- Report Date
- April 6, 2022
- Initiation Date
- March 23, 2022
- Termination Date
- October 5, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 620 vials
Product Description
TESTOSTERONE CYPIONATE/ DHEA *GS* 200/10MG/ML Injectable, Packaged in a multi dose 10ML vial, as a) 5 ML Formula ID 115678; b) 10 ML Formula ID 115498, APS Pharmacy
Reason for Recall
Lack of sterility assurance.
Distribution Pattern
Nationwide in the USA including Puerto Rico.
Code Information
Lots: a)746000 BUD: 6/26/2022; b) 751472 BUD: 7/20/2022